retatrutide glp1 retatrutide Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide in Johnson County -

doi:10.2337/db15-0443 26

Phase Mid escalation Weeks Weeks 9-12 Weekly Dose 4 mg Notes Appetite suppression usually becomes noticeable

Common experiences: Mild nausea in 12% of people, occasional injection site redness, possible mild constipation

All data is from a research context, not a guide to personal use: GI adverse events were dose-dependent and most pronounced during dose escalation

As clinics struggle with shortages and manufacturers warn of supply limits extending well into 2025 and 2026, the demand for easier, faster or cheaper alternatives has exploded

Users can end up lighter but physically weaker, with deteriorating body composition